Astrocyte-Derived Vascular Endothelial Growth Factor Stabilizes Vessels in the Developing Retinal Vasculature

Vascular endothelial growth factor (VEGF) plays a critical role in normal development as well as retinal vasculature disease. During retinal vascularization, VEGF is most strongly expressed by not yet vascularized retinal astrocytes, but also by retinal astrocytes within the developing vascular plexus, suggesting a role for retinal astrocyte-derived VEGF in angiogenesis and vessel network maturation. To test the role of astrocyte-derived VEGF, we used Cre-lox technology in mice to delete VEGF in retinal astrocytes during development. Surprisingly, this only had a minor impact on retinal vasculature development, with only small decreases in plexus spreading, endothelial cell proliferation and survival observed. In contrast, astrocyte VEGF deletion had more pronounced effects on hyperoxia-induced vaso-obliteration and led to the regression of smooth muscle cell-coated radial arteries and veins, which are usually resistant to the vessel-collapsing effects of hyperoxia. These results suggest that VEGF production from retinal astrocytes is relatively dispensable during development, but performs vessel stabilizing functions in the retinal vasculature and might be relevant for retinopathy of prematurity in humans.

[1]  M. Gassmann,et al.  The role of hypoxia-inducible transcription factors in the hypoxic neonatal brain , 2009, Brain and Development.

[2]  J. Micieli,et al.  A systematic analysis of the off-label use of bevacizumab for severe retinopathy of prematurity. , 2009, American journal of ophthalmology.

[3]  C. Betsholtz,et al.  Endothelial-mural cell signaling in vascular development and angiogenesis. , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[4]  J. Stone,et al.  Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity , 1995, Nature Medicine.

[5]  Vishva Dixit,et al.  Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway , 1998, The Journal of Biological Chemistry.

[6]  Philippe Soriano.  Generalized lacZ expression with the ROSA26 Cre reporter strain , 1999, Nature Genetics.

[7]  K. Alitalo,et al.  VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia , 2003, The Journal of cell biology.

[8]  R. Lang,et al.  VEGF deprivation-induced apoptosis is a component of programmed capillary regression. , 1999, Development.

[9]  Lois E. H. Smith,et al.  Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Levy.  Hypoxic regulation of VEGF mRNA stability by RNA-binding proteins. , 1998, Trends in cardiovascular medicine.

[11]  D. Gutmann,et al.  Astrocyte-Specific Inactivation of the Neurofibromatosis 1 Gene (NF1) Is Insufficient for Astrocytoma Formation , 2002, Molecular and Cellular Biology.

[12]  M. Fruttiger,et al.  Oxygen modifies artery differentiation and network morphogenesis in the retinal vasculature , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.

[13]  Marcus Fruttiger,et al.  Stabilization of the retinal vascular network by reciprocal feedback between blood vessels and astrocytes , 2005, Development.

[14]  N. Yang,et al.  Different effects of glucose starvation on expression and stability of VEGF mRNA isoforms in murine ovarian cancer cells. , 2002, Biochemical and biophysical research communications.

[15]  J. Provis,et al.  Development of the human retinal vasculature: cellular relations and VEGF expression. , 1997, Experimental eye research.

[16]  R. Engerman,et al.  Development of retinal vasculature in rats. , 1965, American journal of ophthalmology.

[17]  M. Fruttiger,et al.  Role of arteries in oxygen induced vaso-obliteration. , 2003, Experimental eye research.

[18]  Lois E. H. Smith,et al.  IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth , 2007, Proceedings of the National Academy of Sciences.

[19]  R. Lang,et al.  Macrophages kill capillary cells in G1 phase of the cell cycle during programmed vascular regression. , 1999, Development.

[20]  Lois E. H. Smith,et al.  Oxygen-induced retinopathy in the mouse. , 1994, Investigative ophthalmology & visual science.

[21]  J. Winer,et al.  Aortic smooth muscle cells express and secrete vascular endothelial growth factor. , 1991, Growth factors.

[22]  Leh Smith.  Pathogenesis of retinopathy of prematurity , 2002, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[23]  M Aguet,et al.  VEGF is required for growth and survival in neonatal mice. , 1999, Development.

[24]  A. Hendrickson,et al.  Astrocytes and blood vessels define the foveal rim during primate retinal development. , 2000, Investigative ophthalmology & visual science.

[25]  Akiyoshi Uemura,et al.  Tlx acts as a proangiogenic switch by regulating extracellular assembly of fibronectin matrices in retinal astrocytes. , 2006, The Journal of clinical investigation.

[26]  E. Piek,et al.  Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival. , 2003, Developmental biology.

[27]  E. Keshet,et al.  A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. , 1998, Development.

[28]  J. Stone,et al.  Degeneration of astrocytes in feline retinopathy of prematurity causes failure of the blood-retinal barrier. , 1992, Investigative ophthalmology & visual science.

[29]  J. Stone,et al.  Relationship between astrocytes, ganglion cells and vasculature of the retina , 1987, The Journal of comparative neurology.

[30]  Lois E. H. Smith,et al.  Retinopathy of Prematurity: Current Concepts in Molecular Pathogenesis , 2009, Seminars in ophthalmology.

[31]  E. Keshet,et al.  Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[32]  V. Praloran,et al.  Purification and biological properties of vasculotropin, a new angiogenic cytokine , 1991, Biology of the cell.

[33]  P. Campochiaro,et al.  Implication of the hypoxia response element of the vegf promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development , 2006, Journal of cellular physiology.

[34]  G. Siuzdak,et al.  Maintaining retinal astrocytes normalizes revascularization and prevents vascular pathology associated with oxygen‐induced retinopathy , 2010, Glia.

[35]  T. Chan-Ling,et al.  The effect of oxygen on vasoformative cell division. Evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis. , 1995, Investigative ophthalmology & visual science.

[36]  J. Stone,et al.  Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[37]  Lois E. H. Smith,et al.  Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: Direct correlation with clinical retinopathy of prematurity , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A. Vingrys,et al.  AT1 receptor inhibition prevents astrocyte degeneration and restores vascular growth in oxygen‐induced retinopathy , 2008, Glia.

[39]  J. M. Arbeit,et al.  Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. , 2000, Cancer research.

[40]  Marcus Fruttiger,et al.  Development of the mouse retinal vasculature: angiogenesis versus vasculogenesis. , 2002, Investigative ophthalmology & visual science.

[41]  Lois E. H. Smith,et al.  Erythropoietin deficiency decreases vascular stability in mice. , 2008, The Journal of clinical investigation.

[42]  Andrew P. McMahon,et al.  WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature , 2005, Nature.

[43]  C. Zucker,et al.  Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy. , 1998, The American journal of pathology.

[44]  M. Bartoli,et al.  Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity. , 2002, Investigative ophthalmology & visual science.

[45]  P. J. Clarke,et al.  Double immunocytochemical labeling of cell and tissue samples with monoclonal anti-bromodeoxyuridine. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[46]  Ingeborg Stalmans,et al.  Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. , 2002, The Journal of clinical investigation.

[47]  W. Richardson,et al.  Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice. , 1999, Development.

[48]  P. Chambon,et al.  Efficient, inducible Cre‐recombinase activation in vascular endothelium , 2008, Genesis.

[49]  M. Detmar,et al.  Identification of a human VPF/VEGF 3' untranslated region mediating hypoxia-induced mRNA stability. , 1998, Molecular biology of the cell.

[50]  J. Schnitzer.  Astrocytes in the guinea pig, horse, and monkey retina: Their occurrence coincides with the presence of blood vessels , 1988, Glia.

[51]  J. M. Arbeit,et al.  Hypoxia-inducible Factor-1α Is a Positive Factor in Solid Tumor Growth , 2000 .

[52]  Joan W. Miller,et al.  VEGF164-mediated Inflammation Is Required for Pathological, but Not Physiological, Ischemia-induced Retinal Neovascularization , 2003, The Journal of experimental medicine.